Skip to main content
. 2017 Oct 26;2017:3573082. doi: 10.1155/2017/3573082

Figure 3.

Figure 3

Model (5): despite the stimulation of effector cells (E) by the BCG (B), the immune checkpoints (P) block and deactivate the activities of the effector cells, thereby leading to the development and progression of cancer cells (C).